Market Place
Sourcing Support
Eton Pharma Awarded 2nd Patent for ET-400 Hydrocortisone Solution
07 Nov 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report Q3 2024 Financials on Nov 12
06 Nov 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals, Inc to Acquire Increlex® from Ipsen
03 Oct 2024 //
GLOBENEWSWIRE
Eton Pharma To Attend H.C. Wainwright Global Investment Conference
22 Aug 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals To Report Q2 2024 Results On August 8
30 Jul 2024 //
GLOBENEWSWIRE
Eton Pharma`s ET-400 NDA Accepted By FDA
15 Jul 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
09 May 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
01 May 2024 //
GLOBENEWSWIRE
Eton NDA Submission to FDA for ET-400 Hydrocortisone Solution
30 Apr 2024 //
GLOBENEWSWIRE
Eton Pharma Q1 2024 Results on May 9, 2024
29 Apr 2024 //
GLOBENEWSWIRE
Relief Enters into Exclusive License Agreement with Eton for PKU GOLIKE
22 Mar 2024 //
ACCESSWIRE
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
22 Mar 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Eton to Report Fourth Quarter and Full Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Eton Awarded U.S. Patent for Proprietary Hydrocortisone Formulation
21 Feb 2024 //
GLOBENEWSWIRE
Eton Announces Commercial Availability of Nitisinone Capsules
02 Feb 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Eton to Report Third Quarter 2023 Financial Results on November 9, 2023
30 Oct 2023 //
GLOBENEWSWIRE
Eton Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
04 Oct 2023 //
GLOBENEWSWIRE
Eton to Present at H.C. Wainwright 25th Annual Global Investment Conference
23 Aug 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Eton to Report Q2 2023 Financial Results on Thursday, August 10, 2023
01 Aug 2023 //
GLOBENEWSWIRE
Eton`s dehydrated alcohol injection denied for control issues
29 Jun 2023 //
FIERCE PHARMA
Eton Pharmaceuticals Receives (CRL) for Dehydrated Alcohol Injection
28 Jun 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Eton Pharma Announces Commercial Availability of Betaine Anhydrous for Oral Solu
10 May 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report 1Q 2023 FYR, May 11, 2023
03 May 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 Mar 2023 //
GLOBENEWSWIRE
Eton Pharma Announces Acquisition of Rare Disease Product Candidate ET-600
15 Mar 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results
07 Mar 2023 //
GLOBENEWSWIRE
Eton Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 Jan 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results in November
02 Nov 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product
13 Sep 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global
30 Aug 2022 //
GLOBENEWSWIRE
Fish & Richardson Secures Win for Exela Pharma Sciences
15 Aug 2022 //
BUSINESSWIRE
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
11 Aug 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results
02 Aug 2022 //
GLOBENEWSWIRE
Eton Pharma Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension)
18 Jul 2022 //
GLOBENEWSWIRE
Dr. Reddy`s Announces Acquisition of Injectable Product Portfolio from Eton
25 Jun 2022 //
BUSINESSWIRE
Eton Pharmaceuticals Announces Sale of Hospital Products
24 Jun 2022 //
GLOBENEWSWIRE
U.S. FDA declines to approve Eton Pharma`s anti-seizure drug
28 May 2022 //
REUTERS
Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results
03 May 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
11 Apr 2022 //
GLOBENEWSWIRE
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
11 Apr 2022 //
GLOBENEWSWIRE
Eton Pharma`s Generic Cysteine Hydrochloride Receives Approval in US
08 Apr 2022 //
FDA
Eton Pharma Reports Q4 2021 Financial Results
16 Mar 2022 //
GLOBENEWSWIRE
Eton and ANI Announce Commercial Availability of Carglumic Acid
20 Dec 2021 //
GLOBENEWSWIRE
Eton Pharma Announces Co-Promotion Agreement with Tolmar ALKINDI SPRINKLE®
15 Nov 2021 //
GLOBENEWSWIRE
Eton Pharma and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™
08 Nov 2021 //
GLOBENEWSWIRE
Eton Pharma Announces Acquisition of Approved Orphan Drug Carglumic Acid
28 Oct 2021 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Second Quarter Financial Results
16 Aug 2021 //
GLOBENEWSWIRE
License agreement in the US & Canada with Eton Pharma for ZENEO® Hydrocortisone
16 Jun 2021 //
GLOBENEWSWIRE
Eton Pharma Acquires US & Canadian Rights to ZENEO® Hydrocortisone Autoinjector
15 Jun 2021 //
GLOBENEWSWIRE
Eton Pharmaceuticals Announces FDA Approval of Rezipres
15 Jun 2021 //
GLOBENEWSWIRE
FDA hands a CRL to drugmaker Eton after a delayed inspection
29 May 2021 //
ENDPTS
Eton Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 Jan 2021 //
GLOBENEWSWIRE
Eton Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 Jan 2021 //
BIOSPACE
Eton Announces Acceptance for Filing of NDA for Topiramate Oral Solution
17 Dec 2020 //
NASDAQ
